The Cancer Imaging Facility Shared Resource is a broad service center that supports a range of research in the cancer community. The facility is comprised of a small animal imaging center, a cyclotron center and a probe chemistry core that supports both preclinical and clinical research. The main lab offers optical imaging modalities, including bioluminescence and fluorescence imaging systems, as well as two MicroCT scanners, an ultrasound scanner and cryotome systems for sectioning both tissues and whole animals. Off the main laboratory are rooms housing a 7 Tesla, 30cm horizontal bore MRI system, a MicroSPECT-CT scanner and MicroPET scanners. The cyclotron facility is located nearby in the Lucas center and a system is in place for the safe transport of tracers to the Clark Center and the Nuclear Medicine Department. Additional bench space is available for developing new imaging instruments and for performing procedures on animals. The surgical area has surgical lighting and a portable surgical microscope. Adjacent to the imaging facility are two rooms for housing animals that have either been injected with radionuclides for MicroPET or MicroSPECT imaging, or have been infected with select biosafety level 2 pathogens. A computer lab and administrative offices are also located within the core space. The Shared Resource is managed by two full-time PhD-level scientists, who provide training to users on each of the systems, as well as advice on experiment design, choice of appropriate imaging modality and help with data analysis. The Shared Resource also provides a networked computer server to allow data storage and access, with full data backup and archiving. This resource aims to provide a full array of small animal imaging modalities in a centralized location, allowing users to take advantage of the strengths of each modality within their experiments. We have a training program that enables users to run their own experiments, although assistance is available from both the Shared Resource staff and veterinarians, as necessary. With the building of a new mouse barrier facility adjacent to the Clark Center, a second small animal facility will be created within this barrier, duplicating the instruments present in the current facility, and the two imaging facilities will then run in parallel allowing imaging of the two populations. Academic oversight of this Shared Resource is provided by faculty in the Molecular Imaging Program at Stanford (MIPS), headed by Drs. Christopher Contag and Sam Gambhir.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA124435-08
Application #
8685169
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
8
Fiscal Year
2014
Total Cost
$106,208
Indirect Cost
$38,624
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Ganjoo, Kristen; Hong, Fangxin; Horning, Sandra J et al. (2014) Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404). Leuk Lymphoma 55:768-72
Chiou, Shin-Heng; Kim-Kiselak, Caroline; Risca, Viviana I et al. (2014) A conditional system to specifically link disruption of protein-coding function with reporter expression in mice. Cell Rep 7:2078-86
Zhu, Gefei Alex; Danial, Christina; Liu, Andy et al. (2014) Overall and progression-free survival in metastatic basosquamous cancer: a case series. J Am Acad Dermatol 70:1145-6
Caswell, Deborah R; Chuang, Chen-Hua; Yang, Dian et al. (2014) Obligate progression precedes lung adenocarcinoma dissemination. Cancer Discov 4:781-9
Bartroff, Jay; Lai, Tze Leung; Narasimhan, Balasubramanian (2014) A new approach to designing phase I-II cancer trials for cytotoxic chemotherapies. Stat Med 33:2718-35
Kohrt, Holbrook E; Thielens, Ariane; Marabelle, Aurelien et al. (2014) Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies. Blood 123:678-86
DiCarlo, Joseph; Agarwal-Hashmi, Rajni; Shah, Ami et al. (2014) Cytokine and chemokine patterns across 100 days after hematopoietic stem cell transplantation in children. Biol Blood Marrow Transplant 20:361-9
Chang, Serena; Kohrt, Holbrook; Maecker, Holden T (2014) Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother 63:713-9
Ansari, Celina; Tikhomirov, Grigory A; Hong, Su Hyun et al. (2014) Development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapy. Small 10:566-75, 417
Lavori, Philip W; Dawson, Ree (2014) Introduction to dynamic treatment strategies and sequential multiple assignment randomization. Clin Trials 11:393-399

Showing the most recent 10 out of 24 publications